This article from July last year has been posted before but serves as a reminder.
Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly | 2020-07-02 | BioWorld"Nanodx said that it already has partnered to get the SARS-CoV-2 test system to various outlets – such as airlines and sports leagues – that could use the device, which is about the size of a toaster."As we know from previous SE1 company announcements:
2nd July: USD $2m worth of orders for development and delivery of the COVID sensor
6th October: USD $3m worth of orders for development and delivery of the COVID sensor
9th December: USD $10m in the pipeline for the COVID sensor
From Sensera's quarterly announcement on 28th Jan:
''Sensera has secured a manufacturing agreement predicated on FDA approval, which will be fully disclosed in the event that NanoDX receives the approval'.With FDA EUA submission likely less than a month away (with an approval expected to be swiftly expedited), one can imagine quite a substantial update and growth of orders will be announced. What kind of market reaction will there be if SE1 (currently a $25m MC) announces USD $5m worth of COVID sensor orders? What about USD $10m+?
This is the calm before the storm. Interesting and exciting times ahead.
Cheers
